Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-κB activation due to decreased surface expression

被引:34
|
作者
Siebert, S
Fielding, CA
Williams, BD
Brennan, P
机构
[1] Cardiff Univ, Dept Med Biochem & Immunol, Wales Coll Med, Cardiff CF14 4XX, Wales
[2] Cardiff Univ, Dept Rheumatol, Wales Coll Med, Cardiff CF14 4XX, Wales
来源
FEBS LETTERS | 2005年 / 579卷 / 23期
关键词
tumour necrosis factor; TRAPS; NF-kappa B;
D O I
10.1016/j.febslet.2005.08.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in the extracellular domain of TNF receptor 1 (TNFRSF1A), but the effects of the mutations are controversial. This study shows that reduced NF-kappa B signalling is a feature of four TRAPS mutations. Reduced signalling correlates with reduced surface expression, measured by flow cytometry and microscopy. This suggests that correct formation of the extracellular domain of TNFRSF1A is important for localisation and receptor function. Importantly, our data provides a mechanism for the reduced TNFRSF1 signalling observed in a patient cell line. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:5193 / 5198
页数:6
相关论文
共 50 条
  • [1] Abnormal tumor necrosis factor receptor I cell surface expression and NF-κB activation in tumor necrosis factor receptor-associated periodic syndrome
    Nedjai, Belinda
    Hitman, Graham A.
    Yousaf, Nasim
    Chernajovsky, Yuti
    Stiernberg-Salmela, Susanna
    Pettersson, Tom
    Ranki, Annamari
    Hawkins, Philip N.
    Arkwright, Peter D.
    McDermott, Michael F.
    Turner, Mark D.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (01): : 273 - 283
  • [2] NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
    Osman Nidai Ozes
    Lindsey D. Mayo
    Jason A. Gustin
    Susan R. Pfeffer
    Lawrence M. Pfeffer
    David B. Donner
    Nature, 1999, 401 : 82 - 85
  • [3] NF-κB activation by tumor necrosis factor and interleukin-1
    Cao, Z
    Tanaka, M
    Regnier, C
    Rothe, M
    Yamit-Hezi, A
    Woronicz, JD
    Fuentes, ME
    Durnin, MH
    Dalrymple, SA
    Goeddel, DV
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 : 473 - 483
  • [4] Decreased Expression In NF-κB Essential Modulator Due to a Novel Splice-Site Mutation Causes Ectodermal Dysplasia with Immunodeficiency
    Karakawa, Shuhei
    Okada, Satoshi
    Tsumura, Miyuki
    Mizoguchi, Yoko
    Ohno, Norioki
    Yasunaga, Shin'ichiro
    Ohtsubo, Motoaki
    Kawai, Tomolci
    Nishikomori, Ryuta
    Takihara, Yoshihiro
    Kobayashi, Masao
    BLOOD, 2010, 116 (21) : 724 - 725
  • [5] NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
    Ozes, ON
    Mayo, LD
    Gustin, JA
    Pfeffer, SR
    Pfeffer, LM
    Donner, DB
    NATURE, 1999, 401 (6748) : 82 - 85
  • [6] A novel TNFRSF1A splice mutation associated with increased nuclear factor κappaB (NF-κB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)
    Churchman, S. M.
    Church, L. D.
    Savic, S.
    Coulthard, L. R.
    Hayward, B.
    Nedjai, B.
    Turner, M. D.
    Mathews, R. J.
    Baguley, E.
    Hitman, G. A.
    Gooi, H. C.
    Wood, P. M. D.
    Emery, P.
    McDermott, M. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) : 1589 - 1595
  • [7] TRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-κB
    Soond, SM
    Terry, JL
    Colbert, JD
    Riches, DWH
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (22) : 8334 - 8344
  • [8] Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-α.: Effects dependent on activation of NF-κB and MAP kinases
    Brechter, Anna Bernhold
    Persson, Emma
    Lundgren, Inger
    Lerner, Ulf H.
    BONE, 2008, 43 (01) : 72 - 83
  • [9] Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB
    Aggarwal, BB
    ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 : 6 - 16
  • [10] Tumor necrosis factor receptor I activation of NF-κB dependent gene expression requires nuclear relocalization of SIMPL
    Harrington, MA
    Kwon, HJ
    Vig, E
    Luo, Y
    Tian, J
    Goebl, M
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 355A - 355A